Secondary structure of the 5'-region of PGY1/MDR1 mRNA

FEBS Letters

Volumn 475, Issue 3, 2000, Pages 181-186

  Kostenko, Elena V ^a   Beabealashvilly, Robert Sh ^b   Vlassov, Valentin V ^a   Zenkova, Marina A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Antisense oligonucleotide; PGY1 MDR1; RNA structure

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOSPORIN A; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; RIBONUCLEASE; TAMOXIFEN; VERAPAMIL;

ARTICLE; COMPUTER SIMULATION; GENE EXPRESSION; MOLECULAR MODEL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; RNA BINDING; RNA STRUCTURE; STRUCTURE ANALYSIS;

5' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; P-GLYCOPROTEIN; RNA, MESSENGER;

EID: 0034705849     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01650-1     Document Type: Article

References (39)

1. Goldstain L.J., Galski H., Fojo A., Willingham M., Lai A., Gazdar A., Pirker R., Green A., Crist W., Brodeur G.M., Lieber M., Cossman J., Gottesman M.M., Pastan I. J. Natl. Cancer Inst. 81:1989;116-124.
2. Roninson I.B. Biochem. Pharmacol. 43:1992;95-102.
3. Damiani D., Michieli M., Michelutti A., Melli C., Cerno M. Anticancer Drugs. 4:1993;178-180.
4. List A.F., Spier C., Greer J., Phase I. J. Clin. Oncol. 11:1993;1652-1660.
5. Zalcberg J.R., Hu X.F., Ching M. Cancer Chemother. Pharmacol. 27:1991;290-294.
6. Berman E., Adams M., Osterndof R. Blood. 77:1991;818-825.
7. Sikic B.I. J. Clin. Oncol. 11:1993;1629-1635.
8. Cook, P.D. (1993) in: Antisense Research and Applications (Crook, T. and Leableu, B., Eds.), pp. 149-187, CRC Press, Boca Raton, FL.
9. Bouffard D.Y., Ohkawa T., Kijima H., Irie A. Eur. J. Cancer. 32A:1996;1010-1018.
10. Ho, S.P., Britton, D.H., Stone, B.A., Behrens, D.L., Leffet, Hobbs, F.W., Miller, J.A. and Trainor, G.L. (1996) Nucleic Acids Res. 24, 1901-1907.
11. Alahari S.K. J. Pharmacol. Exp. Ther. 286:1998;419-428.
12. Vickers T.A., Ecker J. Nucleic Acids Res. 20:1992;3945-3953.
13. Southern E.M., Milner N., Mir K.U. Ciba Found. Symp. 209:1997;38-46.
14. Milner N., Mir K.U., Southern E.M. Nat. Biotechnol. 15:1997;537-541.
15. Hakala H., Heinonen P., Iitia A., Lonnberg H. Bioconjug. Chem. 8:1997;378-384.
16. Ho, S.P., Bao, Y., Lesher, T., Malhorta, R., Ma, L.Y., Fluharty, S.J., Sakai (1998) Nat. Biotechnol. 16, 59-63.
17. Lima W.F., Brown-Driver V., Fox M., Hanecak R., Bruice T.W. J. Biol. Chem. 272:1997;625-638.
18. Matveeva O., Felden B., Audlin S., Gestaland R.F., Atkins J.F. Nucleic Acids Res. 25:1997;5010-5016.
19. Mir K.U., Southern E.M. Nat. Biotechnol. 17:1999;788-792.
20. King L.E., Morrison M. Anal. Biochem. 71:1976;223-230.
21. Kostenko E.V., Bibilashvilly R.Sh., Vlassov V.V., Zenkova M.A. Mol. Biol. (Moscow). 34:2000;67-78.
22. Milligan J.F., Groebe D.R., Witherell G.W., Uhlenbeck O.C. Nucleic Acids Res. 15:1987;8783-8798.
23. Ehresmann C., Baudin F., Mougel M., Romby P., Ebel J.-P. Nucleic Acids Res. 15:1987;9109-9128.
24. Bruice T.W., Lima W.F. Biochemistry. 36:1997;5004-5019.
25. Vassilenko S.K., Rythe V.C. Biokhimiya. 40:1975;578-582.
26. Lempereur L., Nicoloso M., Riehl N., Ehresmann C., Ehresmann B., Bachellerie J.-P. Nucleic Acids Res. 13:1985;8339-8357.
27. Devereux J., Haeberli P., Smithies O. Nucleic Acids Res. 12:1984;387-395.
28. Abrahams J.P., van den Berg M., van Batenburg E., Pleij C. Nucleic Acids Res. 18:1990;3035-3044.
29. Zarytova, V.F., Godovicova, T.S., Kutiavin, I.V. and Khalimskaya, L.M. (1987) in: Biophosphates and their Analogues, Synthesis, Structure, Methabolism and Activity (Bruzik, K.S. and Stec, W.S., Eds.), pp. 149-164, Elsevier, Amsterdam.
30. Lakovich, J.R. (1983) in: Principles of Fluorescence Spectroscopy, pp. 270-275, Plenum Press, NY.
31. Hosaka H., Sakabe I., Sakamoto K., Niimi T., Yokoyama S., Takaku H. Biochem. Biophys. Acta. 1218:1994;351-356.
32. Petyuk V.A., Zenkova M.A., Giege R., Vlassov V.V. FEBS Lett. 444:1999;217-221.
33. Petyuk V.A., Zenkova M.A., Giege R., Vlassov V.V. Nucleosides Nucleotides. 18:1999;1459-1461.
34. Ecker, D.J. (1993) in: Antisense Research and Applications (Crook, T. and Leableu, B., Eds.), pp. 387-414, CRC Press, Boca Raton, FL.
35. Dobricov M.I., Gaidamakov S.A., Koshkin A.A., Gainutdinov T.I., Luk'yanchuk N.P., Shishkin G.V., Vlassov V.V. Bioorg. Chem. (Moscow). 23:1997;191-199.
36. Jaroszewski J.W., Kaplan O., Syi J.L., Sehested M., Faustino P.J., Cohen J.S. Cancer Commun. 2:1990;287-294.
37. Corrias M.V., Tonini G.P. Anticancer Res. 12:1992;1431-1438.
38. Chao L., Qureshi A., Ding X., Shan Y. Clin. Sci. 91:1996;93-98.
39. Freier, S.M. (1993) in: Antisense Research and Application (Crook, T. and Leableu, B., Eds.), pp. 67-81, CRC Press, Boca Raton, FL.